Affymetrix (Santa Clara, California) Selected to Genotype More Than 9,000 Framingham Heart Study Samples; SHARE Project to Help Identify Genetic Variants Associated With Heart, Lung, Blood and Sleep Disorders

SANTA CLARA, Calif.--(BUSINESS WIRE)--Sept. 5, 2006--Affymetrix Inc. (Nasdaq:AFFX) announced today that it has been selected by the SHARE (SNP Health Association REsource) project for a large-scale whole-genome association study. As part of the project, Affymetrix will collaborate with the National Heart, Lung, and Blood Institute (NHLBI) and the National Center for Biotechnology Information (NCBI) of the National Institutes of Health to identify genetic variants associated with heart, lung, blood and sleep disorders.

MORE ON THIS TOPIC